The Role of C-reactive Protein in Patient Risk Stratification and Treatment
Atherosclerosis is a chronic inflammatory disease. Several circulating inflammatory markers have been proposed for clinical use due to their ability to predict future cardiovascular events and may be useful for identifying people at high risk who might benefit from specific treatment to reduce this...
Guardado en:
Autores principales: | Ramón Arroyo-Espliguero, María C Viana-Llamas, Alberto Silva-Obregón, Pablo Avanzas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/acd02d4c12464c03a725034e018e8fd6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
por: María Pilar Resano-Barrio, et al.
Publicado: (2020) -
Insights for Stratification of Risk in Brugada Syndrome
por: Daniel García Iglesias, et al.
Publicado: (2019) -
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Ryan Wallace, et al.
Publicado: (2021) -
Time to reconsider risk stratification in dilated cardiomyopathy
por: A. Laina, et al.
Publicado: (2021) -
Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
por: Jorge Romero, et al.
Publicado: (2019)